Ecstasy Is New Drug Of Choice For PTSD

Rick Doblin has been one of the few medical doctors in the United States, or actually make that more or less anywhere in the developed world, willing to stick his neck out and conduct clinical trials of psychedelic drugs.

His work has been variously profiled by the alternative press (including, of course, Under The Influence: The Disinformation Guide to Drugs), but it seems that his time may finally have come for some mainstream acceptance. Benedict Carey profiles the work of Doblin’s Multidisciplinary Association for Psychedelic Studies (MAPS) organization for the New York Times:

Hundreds of Iraq and Afghanistan veterans with post-traumatic stress have recently contacted a husband-and-wife team who work in suburban South Carolina to seek help. Many are desperate, pleading for treatment and willing to travel to get it.

The soldiers have no interest in traditional talking cures or prescription drugs that have given them little relief. They are lining up to try an alternative: MDMA, better known as Ecstasy, a party drug that surfaced in the 1980s and ’90s that can induce pulses of euphoria and a radiating affection. Government regulators criminalized the drug in 1985, placing it on a list of prohibited substances that includes heroin and LSD. But in recent years, regulators have licensed a small number of labs to produce MDMA for research purposes.

“I feel survivor’s guilt, both for coming back from Iraq alive and now for having had a chance to do this therapy,” said Anthony, a 25-year-old living near Charleston, S.C., who asked that his last name not be used because of the stigma of taking the drug. “I’m a different person because of it.”

In a paper posted online Tuesday by the Journal of Psychopharmacology, Michael and Ann Mithoefer, the husband-and-wife team offering the treatment — which combines psychotherapy with a dose of MDMA — write that they found 15 of 21 people who recovered from severe post-traumatic stress in the therapy in the early 2000s reported minor to virtually no symptoms today. Many said they have received other kinds of therapy since then, but not with MDMA.

The Mithoefers — he is a psychiatrist and she is a nurse — collaborated on the study with researchers at the Medical University of South Carolina and the nonprofit Multidisciplinary Association for Psychedelic Studies…

[continues in the New York Times]

, , , , , , ,

  • asshurtmacfags

    Here is an excellent(well, entertaining) related bbc program which examines MDMA and it’s potential as a treatment for ptsd. http://www.dailymotion.com/video/xtwdw1_drugs-live-the-ecstasy-trial-1of2-couchtripper_tech

  • “Big” Richard Johnson

    I prefer pot.

    • asshurtmacfags

      Cannabis kicks ass here for sure, the self-examintory state that one goes into whilst high is great for problem solving, but it is definitely not for everyone. Cannabis has a propensity to cause psychosomatic physical symptoms when dealing with uncomfortable thoughts/feelings. That doesn’t really happen with MDMA, the anxiolytic properties of the drug allow those feelings to be processed with emotional neutrality.

  • Cloudnearly9

    Finally maps on disinfo, old news but good news ^_^

  • BuzzCoastin

    I predict War as a Full Moon Rave is next

  • drokhole

    I’ve heard psilocybin can help, too.

  • alizardx

    There’s been some interesting work on ketamine as depression treatment lately. Apparently, there are problems with long-term MDMA use, but non-issue for short-term PTSD treatment.

21
More in Drugs, Ecstasy, Maps, MDMA, medical science, Psychedelics, PTSD
Marijuana Dispensing Company’s Stock Is Way Too High

Last week we posted a story about legal ways to invest in the medical marijuana boom. One of the suggested companies whose stock is publicly traded, Medbox, says it's stock...

Close